4 July 2019

Determined Statements of Principles (SOPs) for:

Condition SOPs
schistosomiasis 61/2019 62/2019
strongyloidiasis 63/2019 64/2019
irritable bowel syndrome 65/2019 66/2019
subarachnoid haemorrhage 67/2019 68/2019
renal stone disease 69/2019 70/2019

These SOPs revoke the SOPs previously determined for these conditions.

Determined Amendment Statements of Principles (SOPs) for:

Condition SOPs
aortic aneurysm and aortic wall disorders 71/2019 72/2019
osteoarthritis 73/2019 74/2019
morbid obesity 75/2019 76/2019

Summary of Changes

Decided to Undertake Consultation regarding:

Condition Reasons for Decision Date for Final Decision
sensorineural hearing loss Intention to remove one or more factors October 2019
subdural haematoma Intention to remove one or more factors October 2019

Finalised Declarations for:

Condition Declaration Reasons for Decision
malignant melanoma of the skin
psoriasis
monoclonal gammopathy of undetermined significance (MGUS)

Completed Investigations

The above determinations and declarations conclude the previously advertised investigations into: